» Articles » PMID: 26175470

The Effect on Treatment Response of Fibromyalgic Symptoms in Early Rheumatoid Arthritis Patients: Results from the ESPOIR Cohort

Overview
Specialty Rheumatology
Date 2015 Jul 16
PMID 26175470
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate whether patients with RA who belong to the spectrum of fibromyalgic RA (FRA) have an impaired response to treatment measured by traditional activity scores.

Methods: Patients from the ESPOIR cohort were analysed. This prospective cohort included 813 patients with early arthritis not initially receiving DMARDs. Among the 697 patients who met RA classification criteria, we studied two groups, one with and the other without FRA. The following endpoints were compared at 6, 12 and 18 months using a mixed linear regression model: 28-joint DAS (DAS28), Simple Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and HAQ. In addition, attainment of low disease activity (LDA; DAS28 <3.2) and remission (DAS28 <2.6, SDAI <3.3, CDAI <2.8) at these time points was analysed.

Results: Patients with FRA (n = 120) had higher DAS28, SDAI, CDAI and HAQ scores than patients with RA and no fibromyalgic characteristics (n = 548). DAS28 and other DASs started out higher in subjects with FRA, and while they improved to a similar extent to in the isolated RA group, they remained consistently higher among FRA patients. Achievement of LDA and remission was significantly less likely in subjects with FRA.

Conclusion: Patients with FRA and RA will have a similar response to treatment according to the decrease in indexes of disease activity, but may miss the target of remission or LDA.

Citing Articles

The problem of residual pain in the assessment of rheumatoid arthritis activity.

Motyl G, Krupka W, Maslinska M Reumatologia. 2024; 62(3):176-186.

PMID: 39055728 PMC: 11267660. DOI: 10.5114/reum/189779.


Predicting Disease Activity in Rheumatoid Arthritis With the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter?.

Gorzewski A, Heisler A, Neogi T, Muhammad L, Song J, Dunlop D J Rheumatol. 2022; 50(5):684-689.

PMID: 36521924 PMC: 10159881. DOI: 10.3899/jrheum.220507.


Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab.

Choy E, Bykerk V, Lee Y, van Hoogstraten H, Ford K, Praestgaard A Rheumatology (Oxford). 2022; 62(7):2386-2393.

PMID: 36413080 PMC: 10321097. DOI: 10.1093/rheumatology/keac659.


Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome.

Durmaz Y, Ilhanli I Ann Saudi Med. 2021; 41(4):246-252.

PMID: 34420399 PMC: 8380282. DOI: 10.5144/0256-4947.2021.246.


Beyond Rheumatoid Arthritis Evaluation: What are We Missing?.

Espinoza G, Maldonado G, Narvaez J, Guerrero R, Citera G, Rios C Open Access Rheumatol. 2021; 13:45-55.

PMID: 33790666 PMC: 8007602. DOI: 10.2147/OARRR.S298393.


References
1.
Pollard L, Kingsley G, Choy E, Scott D . Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford). 2010; 49(5):924-8. DOI: 10.1093/rheumatology/kep458. View

2.
Ma M, Scott I, Kingsley G, Scott D . Remission in early rheumatoid arthritis. J Rheumatol. 2010; 37(7):1444-53. DOI: 10.3899/jrheum.091131. View

3.
Naranjo A, Ojeda S, Francisco F, Erausquin C, Rua-Figueroa I, Rodriguez-Lozano C . Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability. Ann Rheum Dis. 2002; 61(7):660-1. PMC: 1754142. DOI: 10.1136/ard.61.7.660. View

4.
Verstappen S, Bijlsma J, Verkleij H, Buskens E, Blaauw A, ter Borg E . Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004; 51(3):488-97. DOI: 10.1002/art.20419. View

5.
Wolfe F, Cathey M, Kleinheksel S . Fibrositis (Fibromyalgia) in rheumatoid arthritis. J Rheumatol. 1984; 11(6):814-8. View